New House Oversight Panel Chair Towns Less Combative With Drug Industry
Executive Summary
Drug companies likely will face less combative investigations into their activities by the House Oversight and Government Reform Committee during the 111 Congress
You may also be interested in...
GOP Players In Health Debate: McCain To HELP; Enzi Adds Finance To Resume
In the face of substantially higher Democratic congressional majorities, two Republican senators have ensured their place in the debate over health care reform and providing Americans with access to safe medicines
GOP Players In Health Debate: McCain To HELP; Enzi Adds Finance To Resume
In the face of substantially higher Democratic congressional majorities, two Republican senators have ensured their place in the debate over health care reform and providing Americans with access to safe medicines
PhRMA’s Revised DTC Code Shies Away From Internet; Not Celebrities
The Pharmaceutical Research and Manufacturers of America's revised guidelines for direct-to-consumer advertising steer clear of the Internet, even as drug ads are a growing presence on the Web